STAMFORD, Conn. and MINNEAPOLIS, Jan. 25, 2011 /PRNewswire/ -- Thomas, McNerney & Partners, LLC, a health care venture capital firm that invests in life science and medical technology companies, today announced the promotions of Kathy Tune to Partner and Anya Schiess to Vice President.
"These promotions are much-deserved acknowledgements of the important contributions Kathy and Anya have made as members of the Thomas, McNerney investment team," said James Thomas of Thomas, McNerney. "Both have clearly demonstrated their abilities to identify and assess health care investment opportunities and are ready to assume greater responsibilities within our organization."
Kathy Tune, based in the firm's Minneapolis office, joined Thomas, McNerney in 2003. She focuses primarily on the medical device sector. Previously, she was a health care analyst at Piper Jaffray & Co., covering companies in the medical device, medical supply, and diagnostic areas. Earlier in her career, she was a new product development manager at Solvay, S.A. Kathy has an M.S. in Microbiology from the University of Minnesota and an M.B.A. from the University of Minnesota's Carlson School of Management, where she was a Robert and Gail Buuck Scholar. Kathy is on the board of directors of the Mid-America Healthcare Investors Network and is active with the American Heart Association.
Anya Schiess, based in the firm's Stamford, CT office, joined Thomas, McNerney in 2008 from Medtronic, Inc., where she held several sales and marketing leadership roles in the U.S. and Europe. Prior to Medtronic, Anya was a member of the William Jefferson Clinton Presidential Foundation HIV/AIDS initiative. Earlier in her career, she was a consultant at McKinsey & Company. Anya works across the firm's investment areas, with a particular focus on diagnostic investments. She received her A.B. cum laude from Princeton University and her M.B.A. with honors from the Wharton School at the University of Pennsylvania.
About Thomas, McNerney & Partners
Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management, focused on investing in life science and medical technology companies at all stages of development. In addition to helping entrepreneurs launch companies with seed and early stage funding, the firm provides growth capital to emerging companies to advance clinical development or for product commercialization. Thomas, McNerney & Partners also is involved in spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies and participating in structured financings for public companies, as well as recapitalizations. The firm has offices in Connecticut, Minnesota and California. For further information, please visit www.tm-partners.com.
|SOURCE Thomas, McNerney & Partners, LLC|
Copyright©2010 PR Newswire.
All rights reserved